Vito Vanella
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
The role of the molecular tumor board: learnings from the ROME trial.
Journal: NPJ precision oncology
Published: November 18, 2025
Gene-expression signature predicts autoimmune toxicity in metastatic melanoma.
Journal: Journal for immunotherapy of cancer
Published: June 02, 2025
SIAD onset in a patient affected by metastatic melanoma treated with immune checkpoint inhibitors: the role of nivolumab treatment.
Journal: Melanoma research
Published: January 08, 2025
A Combined Proteomic and Transcriptomic Signature Is Predictive of Response to Anti-PD-1 Treatment: A Retrospective Study in Metastatic Melanoma Patients.
Journal: International journal of molecular sciences
Published: July 23, 2024
Safety and efficacy outcomes of early cessation of anti-PD1 therapy in patients 80 years or older: A retrospective cohort study.
Journal: Cancer letters
Published: March 15, 2024
Impact of cemiplimab treatment duration on clinical outcomes in advanced cutaneous squamous cell carcinoma.
Journal: Cancer immunology, immunotherapy : CII
Published: February 29, 2024
Outcomes of patients with resected stage III/IV acral or mucosal melanoma, treated with adjuvant anti-PD-1 based therapy.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 22, 2023
Longitudinal analysis of the gut microbiota during anti-PD-1 therapy reveals stable microbial features of response in melanoma patients.
Journal: Cell host & microbe
Published: October 17, 2023
Characterization of Age-Associated, Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammatory Index (SII) as Biomarkers of Inflammation in Geriatric Patients with Cancer Treated with Immune Checkpoint Inhibitors: Impact on Efficacy and Survival.
Journal: Cancers
Published: September 18, 2023
Long-term outcomes and persistent toxicities following BRAF/MEK inhibitor therapy for advanced melanoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 01, 2023
IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab.
Journal: Journal of translational medicine
Published: December 12, 2022
Immunotherapy Assessment: A New Paradigm for Radiologists.
Journal: Diagnostics (Basel, Switzerland)
Published: November 17, 2022
Last Updated: 09/26/2026